Keywords
Last Name
Institution

CAROL J BAKER

TitleProfessor
InstitutionBaylor College of Medicine
DepartmentDepartment of Pediatrics
DivisionPediatrics-Infectious Diseases
Address1102 Bates, Suite 1120
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleProfessor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular Virology & Microbiology
    DivisionMolecular Virology & Microbiology


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Foster CE, Edwards MS, Brackett J, Schady DA, Healy CM, Baker CJ. Trichosporonosis in Pediatric Patients With a Hematologic Disorder. J Pediatric Infect Dis Soc. 2017 May 16. PMID: 28510690.
      View in: PubMed
    2. Flores AR, Luna RA, Runge JK, Shelburne SA, Baker CJ. Cluster of fatal group A streptococcal emm87 infection within a single family: molecular basis for invasion and transmission. J Infect Dis. 2017 Apr 05. PMID: 28383686.
      View in: PubMed
    3. Baker CJ. Notice of Data Errors. JAMA. 2017 Jan 24; 317(4):441-442. PMID: 28118445.
      View in: PubMed
    4. Baker CJ. A Time to Save. J Pediatric Infect Dis Soc. 2017 Jan 16. PMID: 28093452.
      View in: PubMed
    5. Chaudhary M, Rench MA, Baker CJ, Singh P, Hans C, Edwards MS. Group B Streptococcal Colonization Among Pregnant Women in Delhi, India. Pediatr Infect Dis J. 2016 Dec 23. PMID: 28027278.
      View in: PubMed
    6. Kobayashi M, Schrag SJ, Alderson MR, Madhi SA, Baker CJ, Sobanjo-Ter Meulen A, Kaslow DC, Smith PG, Moorthy VS, Vekemans J. WHO consultation on group B Streptococcus vaccine development: Report from a meeting held on 27-28 April 2016. Vaccine. 2016 Dec 22. PMID: 28017431.
      View in: PubMed
    7. Edwards MS, Rench MA, Rinaudo CD, Fabbrini M, Tuscano G, Buffi G, Bartolini E, Bonacci S, Baker CJ, Margarit I. Immune Responses to Invasive Group B Streptococcal Disease in Adults. Emerg Infect Dis. 2016 Nov; 22(11):1877-1883. PMID: 27767008.
      View in: PubMed
    8. Kobayashi M, Vekemans J, Baker CJ, Ratner AJ, Le Doare K, Schrag SJ. Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries. F1000Res. 2016; 5:2355. PMID: 27803803.
      View in: PubMed
    9. Baker CJ. Prevention of Meningococcal Infection in the United States: Current Recommendations and Future Considerations. J Adolesc Health. 2016 Aug; 59(2 Suppl):S29-37. PMID: 27449147.
      View in: PubMed
    10. Campisi E, Rinaudo CD, Donati C, Barucco M, Torricelli G, Edwards MS, Baker CJ, Margarit I, Rosini R. Serotype IV Streptococcus agalactiae ST-452 has arisen from large genomic recombination events between CC23 and the hypervirulent CC17 lineages. Sci Rep. 2016; 6:29799. PMID: 27411639; PMCID: PMC4944191.
    11. Bowen MD, Mijatovic-Rustempasic S, Esona MD, Teel EN, Gautam R, Sturgeon M, Azimi PH, Baker CJ, Bernstein DI, Boom JA, Chappell J, Donauer S, Edwards KM, Englund JA, Halasa NB, Harrison CJ, Johnston SH, Klein EJ, McNeal MM, Moffatt ME, Rench MA, Sahni LC, Selvarangan R, Staat MA, Szilagyi PG, Weinberg GA, Wikswo ME, Parashar UD, Payne DC. Rotavirus Strain Trends During the Postlicensure Vaccine Era: United States, 2008-2013. J Infect Dis. 2016 Sep 1; 214(5):732-8. PMID: 27302190.
      View in: PubMed
    12. Ward ML, Mijatovic-Rustempasic S, Roy S, Rungsrisuriyachai K, Boom JA, Sahni LC, Baker CJ, Rench MA, Wikswo ME, Payne DC, Parashar UD, Bowen MD. Molecular characterization of the first G24P[14] rotavirus strain detected in humans. Infect Genet Evol. 2016 May 26. PMID: 27237948.
      View in: PubMed
    13. McDade EJ, Hewlett JL, Moonnumakal SP, Baker CJ. Evaluation of Vancomycin Dosing in Pediatric Cystic Fibrosis Patients. J Pediatr Pharmacol Ther. 2016 Mar-Apr; 21(2):155-61. PMID: 27199623; PMCID: PMC4869773.
    14. Roy S, Rungsrisuriyachai K, Esona MD, Boom JA, Sahni LC, Rench MA, Baker CJ, Wikswo ME, Payne DC, Parashar UD, Bowen MD. G2P[4]-RotaTeq Reassortant Rotavirus in Vaccinated Child, United States. Emerg Infect Dis. 2015 Nov; 21(11):2103-4. PMID: 26488454.
      View in: PubMed
    15. Payne DC, Selvarangan R, Azimi PH, Boom JA, Englund JA, Staat MA, Halasa NB, Weinberg GA, Szilagyi PG, Chappell J, McNeal M, Klein EJ, Sahni LC, Johnston SH, Harrison CJ, Baker CJ, Bernstein DI, Moffatt ME, Tate JE, Mijatovic-Rustempasic S, Esona MD, Wikswo ME, Curns AT, Sulemana I, Bowen MD, Gentsch JR, Parashar UD. Long-term Consistency in Rotavirus Vaccine Protection: RV5 and RV1 Vaccine Effectiveness in US Children, 2012-2013. Clin Infect Dis. 2015 Dec 15; 61(12):1792-9. PMID: 26449565.
      View in: PubMed
    16. Flores AR, Galloway-Peña J, Sahasrabhojane P, Saldaña M, Yao H, Su X, Ajami NJ, Holder ME, Petrosino JF, Thompson E, Margarit Y Ros I, Rosini R, Grandi G, Horstmann N, Teatero S, McGeer A, Fittipaldi N, Rappuoli R, Baker CJ, Shelburne SA. Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes. Proc Natl Acad Sci U S A. 2015 May 19; 112(20):6431-6. PMID: 25941374.
      View in: PubMed
    17. Edwards MS, Rench MA, Baker CJ. Relevance of age at diagnosis to prevention of late-onset group B streptococcal disease by maternal immunization. Pediatr Infect Dis J. 2015 May; 34(5):538-9. PMID: 25545183.
      View in: PubMed
    18. Krenek LM, Eldin KW, Baker CJ. Nine-year-old girl with a left flank mass. Clin Pediatr (Phila). 2015 Jun; 54(7):703-5. PMID: 25520369.
      View in: PubMed
    19. Flores AE, Chhatwal GS, Hillier SL, Baker CJ, Ferrieri P. Expression of group B protective surface protein (BPS) by invasive and colonizing isolates of group B streptococci. Curr Microbiol. 2014 Dec; 69(6):894-8. PMID: 25108378.
      View in: PubMed
    20. Oster G, Edelsberg J, Hennegan K, Lewin C, Narasimhan V, Slobod K, Edwards MS, Baker CJ. Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective? Vaccine. 2014 Aug 20; 32(37):4778-85. PMID: 24992717.
      View in: PubMed
    21. Middleman AB, Baker CJ, Kozinetz CA, Kamili S, Nguyen C, Hu DJ, Spradling PR. Duration of protection after infant hepatitis B vaccination series. Pediatrics. 2014 Jun; 133(6):e1500-7. PMID: 24843060.
      View in: PubMed
    22. Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, Walter EB, Jackson LA, Englund JA, Edwards MS, Healy CM, Petrie CR, Ferreira J, Goll JB, Baker CJ. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA. 2014 May 7; 311(17):1760-9. PMID: 24794369; PMCID: PMC4333147.
    23. Baker CJ, Carey VJ, Rench MA, Edwards MS, Hillier SL, Kasper DL, Platt R. Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis. 2014 Mar 1; 209(5):781-8. PMID: 24133184; PMCID: PMC3923540.
    24. Baker CJ. The spectrum of perinatal group B streptococcal disease. Vaccine. 2013 Aug 28; 31 Suppl 4:D3-6. PMID: 23973344.
      View in: PubMed
    25. Healy CM, Rench MA, Baker CJ. Reply to Leuridan et al. Clin Infect Dis. 2013 Aug; 57(3):472-3. PMID: 23580734.
      View in: PubMed
    26. Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, Baker CJ, Messonnier NE. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2013 Mar 22; 62(RR-2):1-28. PMID: 23515099.
      View in: PubMed
    27. Payne DC, Boom JA, Staat MA, Edwards KM, Szilagyi PG, Klein EJ, Selvarangan R, Azimi PH, Harrison C, Moffatt M, Johnston SH, Sahni LC, Baker CJ, Rench MA, Donauer S, McNeal M, Chappell J, Weinberg GA, Tasslimi A, Tate JE, Wikswo M, Curns AT, Sulemana I, Mijatovic-Rustempasic S, Esona MD, Bowen MD, Gentsch JR, Parashar UD. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis. 2013 Jul; 57(1):13-20. PMID: 23487388; PMCID: PMC4618548.
    28. Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis. 2013 Feb; 56(4):539-44. PMID: 23097585.
      View in: PubMed
    29. Boom JA, Sahni LC, Payne DC, Gautam R, Lyde F, Mijatovic-Rustempasic S, Bowen MD, Tate JE, Rench MA, Gentsch JR, Parashar UD, Baker CJ. Symptomatic infection and detection of vaccine and vaccine-reassortant rotavirus strains in 5 children: a case series. J Infect Dis. 2012 Oct; 206(8):1275-9. PMID: 22872730; PMCID: PMC4618559.
    30. Libster R, Edwards KM, Levent F, Edwards MS, Rench MA, Castagnini LA, Cooper T, Sparks RC, Baker CJ, Shah PE. Long-term outcomes of group B streptococcal meningitis. Pediatrics. 2012 Jul; 130(1):e8-15. PMID: 22689869.
      View in: PubMed
    31. Edwards MS, Lane HJ, Hillier SL, Rench MA, Baker CJ. Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines. Vaccine. 2012 Jun 13; 30(28):4123-6. PMID: 22537994; PMCID: PMC3392193.
    32. Healy CM, Baker CJ, Palazzi DL, Campbell JR, Edwards MS. Distinguishing true coagulase-negative Staphylococcus infections from contaminants in the neonatal intensive care unit. J Perinatol. 2013 Jan; 33(1):52-8. PMID: 22499081.
      View in: PubMed
    33. Healy CM, Baker CJ. Infant pertussis: what to do next? Clin Infect Dis. 2012 Feb 1; 54(3):328-30. PMID: 22156848.
      View in: PubMed
    34. Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis. 2012 Jan 1; 54(1):78-84. PMID: 22075790.
      View in: PubMed
    35. Baker CJ. Help make your school a flu-free zone. NASN Sch Nurse. 2011 Nov; 26(6):364-7. PMID: 22165485.
      View in: PubMed
    36. Campbell JR, Hulten K, Baker CJ. Cluster of Bacillus species bacteremia cases in neonates during a hospital construction project. Infect Control Hosp Epidemiol. 2011 Oct; 32(10):1035-8. PMID: 21931256.
      View in: PubMed
    37. Policy statement—Recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics. 2011 Sep; 128(3):611-6. PMID: 21807694.
      View in: PubMed
    38. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011 Jan 15; 52(2):157-62. PMID: 21288837.
      View in: PubMed
    39. Boom JA, Tate JE, Sahni LC, Rench MA, Quaye O, Mijatovic-Rustempasic S, Patel MM, Baker CJ, Parashar UD. Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital. Pediatr Infect Dis J. 2010 Dec; 29(12):1133-5. PMID: 20634776.
      View in: PubMed
    40. Levent F, Baker CJ, Rench MA, Edwards MS. Early outcomes of group B streptococcal meningitis in the 21st century. Pediatr Infect Dis J. 2010 Nov; 29(11):1009-12. PMID: 20555292.
      View in: PubMed
    41. Patel M, Rench MA, Boom JA, Tate JE, Sahni LC, Hull JA, Gentsch JR, Parashar UD, Baker CJ. Detection of rotavirus antigenemia in routinely obtained serum specimens to augment surveillance and vaccine effectiveness evaluations. Pediatr Infect Dis J. 2010 Sep; 29(9):836-9. PMID: 20526226.
      View in: PubMed
    42. Sahni LC, Boom JA, Patel MM, Baker CJ, Rench MA, Parashar UD, Tate JE. Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children. Vaccine. 2010 Aug 31; 28(38):6314-7. PMID: 20637764.
      View in: PubMed
    43. Lantos PM, Charini WA, Medoff G, Moro MH, Mushatt DM, Parsonnet J, Sanders JW, Baker CJ. Final report of the Lyme disease review panel of the Infectious Diseases Society of America. Clin Infect Dis. 2010 Jul 1; 51(1):1-5. PMID: 20504239.
      View in: PubMed
    44. Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, Patel MM, Baker CJ, Parashar UD. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010 Feb; 125(2):e199-207. PMID: 20083525.
      View in: PubMed
    45. Bobo N, Baker CJ. Practice what we teach. The case for influenza vaccination among school nurses. NASN Sch Nurse. 2009 Nov; 24(6):243-5. PMID: 20440938.
      View in: PubMed
    46. Pickering LK, Baker CJ, Freed GL, Gall SA, Grogg SE, Poland GA, Rodewald LE, Schaffner W, Stinchfield P, Tan L, Zimmerman RK, Orenstein WA. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2009 Sep 15; 49(6):817-40. PMID: 19659433.
      View in: PubMed
    47. Healy CM, Rench MA, Castagnini LA, Baker CJ. Pertussis immunization in a high-risk postpartum population. Vaccine. 2009 Sep 18; 27(41):5599-602. PMID: 19647062.
      View in: PubMed
    48. Pannaraj PS, Edwards MS, Ewing KT, Lewis AL, Rench MA, Baker CJ. Group B streptococcal conjugate vaccines elicit functional antibodies independent of strain O-acetylation. Vaccine. 2009 Jul 16; 27(33):4452-6. PMID: 19490960; PMCID: PMC2778198.
    49. Margarit I, Rinaudo CD, Galeotti CL, Maione D, Ghezzo C, Buttazzoni E, Rosini R, Runci Y, Mora M, Buccato S, Pagani M, Tresoldi E, Berardi A, Creti R, Baker CJ, Telford JL, Grandi G. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis. 2009 Jan 1; 199(1):108-15. PMID: 19086816.
      View in: PubMed
    50. Healy CM, Baker CJ. Fluconazole prophylaxis in the neonatal intensive care unit. Pediatr Infect Dis J. 2009 Jan; 28(1):49-52. PMID: 19106754.
      View in: PubMed
    51. Healy CM, Campbell JR, Zaccaria E, Baker CJ. Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species. Pediatrics. 2008 Apr; 121(4):703-10. PMID: 18381534.
      View in: PubMed
    52. Bartlett AH, Rivera AL, Krishnamurthy R, Baker CJ. Thoracic actinomycosis in children: case report and review of the literature. Pediatr Infect Dis J. 2008 Feb; 27(2):165-9. PMID: 18174864.
      View in: PubMed
    53. Pannaraj PS, Kelly JK, Rench MA, Madoff LC, Edwards MS, Baker CJ. Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease. Vaccine. 2008 Jan 24; 26(4):502-8. PMID: 18155812; PMCID: PMC2581930.
    54. Baker CJ. Another success for hepatitis A vaccine. N Engl J Med. 2007 Oct 25; 357(17):1757-9. PMID: 17947391.
      View in: PubMed
    55. Healy CM, Baker CJ. Maternal immunization. Pediatr Infect Dis J. 2007 Oct; 26(10):945-8. PMID: 17901801.
      View in: PubMed
    56. Baker CJ, Schaffner W, Zimmerman RK. Importance of influenza vaccination for children. Am Fam Physician. 2007 Aug 1; 76(3):343-4; author reply 344, 347. PMID: 17708132.
      View in: PubMed
    57. Pannaraj PS, Kelly JK, Madoff LC, Rench MA, Lachenauer CS, Edwards MS, Baker CJ. Group B Streptococcus bacteremia elicits beta C protein-specific IgMand IgG in humans. J Infect Dis. 2007 Feb 1; 195(3):353-6. PMID: 17205473.
      View in: PubMed
    58. Baker CJ, Rench MA, Paoletti LC, Edwards MS. Dose-response to type V group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine in healthy adults. Vaccine. 2007 Jan 2; 25(1):55-63. PMID: 16919857.
      View in: PubMed
    59. Manning SD, Ki M, Marrs CF, Kugeler KJ, Borchardt SM, Baker CJ, Foxman B. The frequency of genes encoding three putative group B streptococcal virulence factors among invasive and colonizing isolates. BMC Infect Dis. 2006; 6:116. PMID: 16846499; PMCID: PMC1559624.
    60. Bartlett AH, Dishop MK, Baker CJ. An unusual cause of appendicitis in a child. Semin Pediatr Infect Dis. 2006 Jul; 17(3):111-2, 177-9. PMID: 16934704.
      View in: PubMed
    61. Healy CM, Baker CJ. Prospects for prevention of childhood infections by maternal immunization. Curr Opin Infect Dis. 2006 Jun; 19(3):271-6. PMID: 16645489.
      View in: PubMed
    62. Healy CM, Rench MA, Edwards KM, Baker CJ. Pertussis serostatus among neonates born to Hispanic women. Clin Infect Dis. 2006 May 15; 42(10):1439-42. PMID: 16619157.
      View in: PubMed
    63. Pannaraj PS, Walsh TJ, Baker CJ. Advances in antifungal therapy. Pediatr Infect Dis J. 2005 Oct; 24(10):921-2. PMID: 16220093.
      View in: PubMed
    64. Edwards MS, Baker CJ. Group B streptococcal infections in elderly adults. Clin Infect Dis. 2005 Sep 15; 41(6):839-47. PMID: 16107984.
      View in: PubMed
    65. Healy CM, Baker CJ, Zaccaria E, Campbell JR. Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit. J Pediatr. 2005 Aug; 147(2):166-71. PMID: 16126043.
      View in: PubMed
    66. Amundson NR, Flores AE, Hillier SL, Baker CJ, Ferrieri P. DNA macrorestriction analysis of nontypeable group B streptococcal isolates: clonal evolution of nontypeable and type V isolates. J Clin Microbiol. 2005 Feb; 43(2):572-6. PMID: 15695647; PMCID: PMC548113.
    67. Healy CM, Baker CJ. The future of meningococcal vaccines. Pediatr Infect Dis J. 2005 Feb; 24(2):175-6. PMID: 15702048.
      View in: PubMed
    68. Edwards MS, Rench MA, Palazzi DL, Baker CJ. Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons. Clin Infect Dis. 2005 Feb 1; 40(3):352-7. PMID: 15668856.
      View in: PubMed
    69. Healy CM, Hulten KG, Palazzi DL, Campbell JR, Baker CJ. Emergence of new strains of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Clin Infect Dis. 2004 Nov 15; 39(10):1460-6. PMID: 15546082.
      View in: PubMed
    70. Healy CM, Palazzi DL, Edwards MS, Campbell JR, Baker CJ. Features of invasive staphylococcal disease in neonates. Pediatrics. 2004 Oct; 114(4):953-61. PMID: 15466090.
      View in: PubMed
    71. Edwards MS, Munoz FM, Baker CJ. Antibodies to type III group B streptococcal polysaccharide in breast milk. Pediatr Infect Dis J. 2004 Oct; 23(10):961-3. PMID: 15602200.
      View in: PubMed
    72. Manning SD, Neighbors K, Tallman PA, Gillespie B, Marrs CF, Borchardt SM, Baker CJ, Pearlman MD, Foxman B. Prevalence of group B streptococcus colonization and potential for transmission by casual contact in healthy young men and women. Clin Infect Dis. 2004 Aug 1; 39(3):380-8. PMID: 15307006.
      View in: PubMed
    73. Palazzi DL, Rench MA, Edwards MS, Baker CJ. Use of type V group B streptococcal conjugate vaccine in adults 65-85 years old. J Infect Dis. 2004 Aug 1; 190(3):558-64. PMID: 15243932.
      View in: PubMed
    74. Healy CM, Munoz FM, Rench MA, Halasa NB, Edwards KM, Baker CJ. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis. 2004 Jul 15; 190(2):335-40. PMID: 15216470.
      View in: PubMed
    75. Baker CJ, Paoletti LC, Rench MA, Guttormsen HK, Edwards MS, Kasper DL. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis. 2004 Mar 15; 189(6):1103-12. PMID: 14999615.
      View in: PubMed
    76. Davies HD, Jones N, Whittam TS, Elsayed S, Bisharat N, Baker CJ. Multilocus sequence typing of serotype III group B streptococcus and correlation with pathogenic potential. J Infect Dis. 2004 Mar 15; 189(6):1097-102. PMID: 14999614.
      View in: PubMed
    77. Borchardt SM, Foxman B, Chaffin DO, Rubens CE, Tallman PA, Manning SD, Baker CJ, Marrs CF. Comparison of DNA dot blot hybridization and lancefield capillary precipitin methods for group B streptococcal capsular typing. J Clin Microbiol. 2004 Jan; 42(1):146-50. PMID: 14715745; PMCID: PMC321726.
    78. Amaya RA, Baker CJ, Keitel WA, Edwards MS. Healthy elderly people lack neutrophil-mediated functional activity to type V group B Streptococcus. J Am Geriatr Soc. 2004 Jan; 52(1):46-50. PMID: 14687314.
      View in: PubMed
    79. Englund JA, Raskino C, Vavro C, Palumbo P, Ross LL, McKinney R, Nikolic-Djokic D, Colgrove RC, Baker CJ. Mutations linked to drug resistance, human immunodeficiency virus type 1 biologic phenotype and their association with disease progression in children receiving nucleoside reverse transcriptase inhibitors. Pediatr Infect Dis J. 2004 Jan; 23(1):15-22. PMID: 14743040.
      View in: PubMed
    80. Chantry CJ, Byrd RS, Englund JA, Baker CJ, McKinney RE. Growth, survival and viral load in symptomatic childhood human immunodeficiency virus infection. Pediatr Infect Dis J. 2003 Dec; 22(12):1033-9. PMID: 14688560.
      View in: PubMed
    81. Baker CJ, Rench MA, McInnes P. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. Vaccine. 2003 Jul 28; 21(24):3468-72. PMID: 12850362.
      View in: PubMed
    82. Kanto WP, Baker CJ. New recommendations for prevention of early-onset group B streptococcal disease in newborns. Pediatr Rev. 2003 Jul; 24(7):219-21. PMID: 12837958.
      View in: PubMed
    83. Baker CJ, Rench MA, Fernandez M, Paoletti LC, Kasper DL, Edwards MS. Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis. 2003 Jul 1; 188(1):66-73. PMID: 12825173.
      View in: PubMed
    84. Baker CJ, Edwards MS. Group B streptococcal conjugate vaccines. Arch Dis Child. 2003 May; 88(5):375-8. PMID: 12716700; PMCID: PMC1719562.
    85. Capparelli EV, Englund JA, Connor JD, Spector SA, McKinney RE, Palumbo P, Baker CJ. Population pharmacokinetics and pharmacodynamics of zidovudine in HIV-infected infants and children. J Clin Pharmacol. 2003 Feb; 43(2):133-40. PMID: 12616665.
      View in: PubMed
    86. Manning SD, Foxman B, Pierson CL, Tallman P, Baker CJ, Pearlman MD. Correlates of antibiotic-resistant group B streptococcus isolated from pregnant women. Obstet Gynecol. 2003 Jan; 101(1):74-9. PMID: 12517649.
      View in: PubMed
    87. Manning SD, Tallman P, Baker CJ, Gillespie B, Marrs CF, Foxman B. Determinants of co-colonization with group B streptococcus among heterosexual college couples. Epidemiology. 2002 Sep; 13(5):533-9. PMID: 12192222.
      View in: PubMed
    88. Benson JA, Flores AE, Baker CJ, Hillier SL, Ferrieri P. Improved methods for typing nontypeable isolates of group B streptococci. Int J Med Microbiol. 2002 Jun; 292(1):37-42. PMID: 12139427.
      View in: PubMed
    89. Brigtsen AK, Kasper DL, Baker CJ, Jennings HJ, Guttormsen HK. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines. J Infect Dis. 2002 May 1; 185(9):1277-84. PMID: 12001045.
      View in: PubMed
    90. Guttormsen HK, Baker CJ, Nahm MH, Paoletti LC, Zughaier SM, Edwards MS, Kasper DL. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14. Infect Immun. 2002 Apr; 70(4):1724-38. PMID: 11895934; PMCID: PMC127872.
    91. Amaya RA, Baker CJ. Bilateral lung abscesses in an adolescent. Semin Pediatr Infect Dis. 2002 Apr; 13(2):71, 142. PMID: 12122954.
      View in: PubMed
    92. Lachenauer CS, Baker CJ, Baron MJ, Kasper DL, Gravekamp C, Madoff LC. Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. J Infect Dis. 2002 Feb 1; 185(3):368-74. PMID: 11807719.
      View in: PubMed
    93. Bliss SJ, Manning SD, Tallman P, Baker CJ, Pearlman MD, Marrs CF, Foxman B. Group B Streptococcus colonization in male and nonpregnant female university students: a cross-sectional prevalence study. Clin Infect Dis. 2002 Jan 15; 34(2):184-90. PMID: 11740706.
      View in: PubMed
    94. Petrov T, Shapiro Y, Baker C, Duff JP, Sanders EJ, Gordon T, Smith PA. Peripheral target contact regulates Ca2+ channels in the cell bodies of bullfrog sympathetic ganglion B-neurons. Auton Neurosci. 2001 Jun 20; 89(1-2):74-85. PMID: 11474650.
      View in: PubMed
    95. Moylett E, Chung T, Baker CJ. Magnetic resonance imaging in a child with primary sternal osteomyelitis. Pediatr Infect Dis J. 2001 May; 20(5):547-50. PMID: 11368120.
      View in: PubMed
    96. Fernandez M, Rench MA, Albanyan EA, Edwards MS, Baker CJ. Failure of rifampin to eradicate group B streptococcal colonization in infants. Pediatr Infect Dis J. 2001 Apr; 20(4):371-6. PMID: 11332660.
      View in: PubMed
    97. Campbell JR, Hillier SL, Krohn MA, Ferrieri P, Zaleznik DF, Baker CJ. Group B streptococcal colonization and serotype-specific immunity in pregnant women at delivery. Obstet Gynecol. 2000 Oct; 96(4):498-503. PMID: 11004347.
      View in: PubMed
    98. Baker CJ, Paoletti LC, Rench MA, Guttormsen HK, Carey VJ, Hickman ME, Kasper DL. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. J Infect Dis. 2000 Oct; 182(4):1129-38. PMID: 10979909.
      View in: PubMed
    99. Fernandez M, Moylett EH, Noyola DE, Baker CJ. Candidal meningitis in neonates: a 10-year review. Clin Infect Dis. 2000 Aug; 31(2):458-63. PMID: 10987705.
      View in: PubMed
    100. Fernandez M, Carrol CL, Baker CJ. Discitis and vertebral osteomyelitis in children: an 18-year review. Pediatrics. 2000 Jun; 105(6):1299-304. PMID: 10835072.
      View in: PubMed
    101. Campbell JR, Zaccaria E, Baker CJ. Systemic candidiasis in extremely low birth weight infants receiving topical petrolatum ointment for skin care: a case-control study. Pediatrics. 2000 May; 105(5):1041-5. PMID: 10790460.
      View in: PubMed
    102. Moylett EH, Fernandez M, Rench MA, Hickman ME, Baker CJ. A 5-year review of recurrent group B streptococcal disease: lessons from twin infants. Clin Infect Dis. 2000 Feb; 30(2):282-7. PMID: 10671329.
      View in: PubMed
    103. Hickman ME, Rench MA, Ferrieri P, Baker CJ. Changing epidemiology of group B streptococcal colonization. Pediatrics. 1999 Aug; 104(2 Pt 1):203-9. PMID: 10428995.
      View in: PubMed
    104. Fernandez M, Rench MA, Baker CJ. Neonatal sepsis caused simultaneously by two serotypes of group B Streptococcus. Pediatr Infect Dis J. 1999 Apr; 18(4):391-3. PMID: 10223702.
      View in: PubMed
    105. Baker CJ, Paoletti LC, Wessels MR, Guttormsen HK, Rench MA, Hickman ME, Kasper DL. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis. 1999 Jan; 179(1):142-50. PMID: 9841833.
      View in: PubMed
    106. Campbell JR, Zaccaria E, Mason EO, Baker CJ. Epidemiological analysis defining concurrent outbreaks of Serratia marcescens and methicillin-resistant Staphylococcus aureus in a neonatal intensive-care unit. Infect Control Hosp Epidemiol. 1998 Dec; 19(12):924-8. PMID: 9872530.
      View in: PubMed
    107. Albanyan EA, Baker CJ. Is lumbar puncture necessary to exclude meningitis in neonates and young infants: lessons from the group B streptococcus cellulitis- adenitis syndrome. Pediatrics. 1998 Oct; 102(4 Pt 1):985-6. PMID: 9786777.
      View in: PubMed
    108. Gurwitch KD, Goldwire MA, Baker CJ. Intravenous immune globulin shortage: experience at a large children's hospital. Pediatrics. 1998 Sep; 102(3 Pt 1):645-7. PMID: 9738190.
      View in: PubMed
    109. Ussery XT, Annunziato P, Gershon AA, Reid BS, Lungu O, Langston C, Silverstein S, Lee KK, Baker CJ. Congenital varicella-zoster virus infection and Barrett's esophagus. J Infect Dis. 1998 Aug; 178(2):539-43. PMID: 9697739.
      View in: PubMed
    110. Fernandez M, Hickman ME, Baker CJ. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother. 1998 Jun; 42(6):1517-9. PMID: 9624508; PMCID: PMC105636.
    111. Gaglani MJ, Baker CJ, Edwards MS. Contribution of antibody to neutrophil-mediated killing of Enterococcus faecalis. J Clin Immunol. 1997 Nov; 17(6):478-84. PMID: 9418188.
      View in: PubMed
    112. Fernandez M, Dreyer Z, Hockenberry-Eaton M, Baker CJ. Methylobacterium mesophilica as a cause of persistent bacteremia in a child with lymphoma. Pediatr Infect Dis J. 1997 Oct; 16(10):1007-8. PMID: 9380457.
      View in: PubMed
    113. Englund JA, Baker CJ, Raskino C, McKinney RE, Petrie B, Fowler MG, Pearson D, Gershon A, McSherry GD, Abrams EJ, Schliozberg J, Sullivan JL. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med. 1997 Jun 12; 336(24):1704-12. PMID: 9182213.
      View in: PubMed
    114. Trainer VL, McPhee JC, Boutelet-Bochan H, Baker C, Scheuer T, Babin D, Demoute JP, Guedin D, Catterall WA. High affinity binding of pyrethroids to the alpha subunit of brain sodium channels. Mol Pharmacol. 1997 Apr; 51(4):651-7. PMID: 9106631.
      View in: PubMed
    115. Baker CJ. Group B streptococcal infections. Clin Perinatol. 1997 Mar; 24(1):59-70. PMID: 9099502.
      View in: PubMed
    116. Khan EA, Correa AG, Baker CJ. Suppurative thrombophlebitis in children: a ten-year experience. Pediatr Infect Dis J. 1997 Jan; 16(1):63-7. PMID: 9002104.
      View in: PubMed
    117. Vallejo JG, Baker CJ, Edwards MS. Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci. Infect Immun. 1996 Dec; 64(12):5042-6. PMID: 8945544; PMCID: PMC174486.
    118. Englund JA, Baker CJ, Raskino C, McKinney RE, Lifschitz MH, Petrie B, Fowler MG, Connor JD, Mendez H, O'Donnell K, Wara DW. Clinical and laboratory characteristics of a large cohort of symptomatic, human immunodeficiency virus-infected infants and children. AIDS Clinical Trials Group Protocol 152 Study Team. Pediatr Infect Dis J. 1996 Nov; 15(11):1025-36. PMID: 8933553.
      View in: PubMed
    119. Campbell JR, Arango CA, Garcia-Prats JA, Baker CJ. An outbreak of M serotype 1 group A Streptococcus in a neonatal intensive care unit. J Pediatr. 1996 Sep; 129(3):396-402. PMID: 8804329.
      View in: PubMed
    120. Vallejo JG, Baker CJ, Edwards MS. Interleukin-6 production by human neonatal monocytes stimulated by type III group B streptococci. J Infect Dis. 1996 Aug; 174(2):332-7. PMID: 8699063.
      View in: PubMed
    121. Baker CJ. Inadequacy of rapid immunoassays for intrapartum detection of group B streptococcal carriers. Obstet Gynecol. 1996 Jul; 88(1):51-5. PMID: 8684761.
      View in: PubMed
    122. Rowen JL, Doerr CA, Vogel H, Baker CJ. Balamuthia mandrillaris: a newly recognized agent for amebic meningoencephalitis. Pediatr Infect Dis J. 1995 Aug; 14(8):705-10. PMID: 8532431.
      View in: PubMed
    123. Rowen JL, Atkins JT, Levy ML, Baer SC, Baker CJ. Invasive fungal dermatitis in the < or = 1000-gram neonate. Pediatrics. 1995 May; 95(5):682-7. PMID: 7724303.
      View in: PubMed
    124. Green PA, Singh KV, Murray BE, Baker CJ. Recurrent group B streptococcal infections in infants: clinical and microbiologic aspects. J Pediatr. 1994 Dec; 125(6 Pt 1):931-8. PMID: 7996368.
      View in: PubMed
    125. Lindsay CA, Dang K, Adams JM, Ou CN, Baker CJ. Stability and activity of intravenous immunoglobulin with neonatal dextrose and total parenteral nutrient solutions. Ann Pharmacother. 1994 Sep; 28(9):1014-7. PMID: 7803872.
      View in: PubMed
    126. Vallejo JG, Baker CJ, Edwards MS. Demonstration of circulating group B streptococcal immune complexes in neonates with meningitis. J Clin Microbiol. 1994 Sep; 32(9):2041-5. PMID: 7814522; PMCID: PMC263938.
    127. Hall MA, Hickman ME, Baker CJ, Edwards MS. Complement and antibody in neutrophil-mediated killing of type V group B streptococcus. J Infect Dis. 1994 Jul; 170(1):88-93. PMID: 8014526.
      View in: PubMed
    128. Correa AG, Baker CJ, Schutze GE, Edwards MS. Immunoglobulin G enhances C3 degradation on coagulase-negative staphylococci. Infect Immun. 1994 Jun; 62(6):2362-6. PMID: 8188359; PMCID: PMC186519.
    129. Rowen JL, Rench MA, Kozinetz CA, Adams JM, Baker CJ. Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates. J Pediatr. 1994 May; 124(5 Pt 1):789-94. PMID: 8176570.
      View in: PubMed
    130. Baker CJ. Vaccine prevention of group B streptococcal disease. Pediatr Ann. 1993 Dec; 22(12):711-4. PMID: 8139871.
      View in: PubMed
    131. Edwards MS, Wessels MR, Baker CJ. Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci. Infect Immun. 1993 Jul; 61(7):2866-71. PMID: 8514389; PMCID: PMC280932.
    132. Noya FJ, Baker CJ, Edwards MS. Neutrophil Fc receptor participation in phagocytosis of type III group B streptococci. Infect Immun. 1993 Apr; 61(4):1415-20. PMID: 8454344; PMCID: PMC281379.
    133. Rench MA, Baker CJ. Neonatal sepsis caused by a new group B streptococcal serotype. J Pediatr. 1993 Apr; 122(4):638-40. PMID: 8463918.
      View in: PubMed
    134. Dimitrov DH, Hollinger FB, Baker CJ, Kline MW, Doyle M, Bremer JW, Shearer WT. Study of human immunodeficiency virus resistance to 2'-3'-dideoxyinosine and zidovudine in sequential isolates from pediatric patients on long-term therapy. J Infect Dis. 1993 Apr; 167(4):818-23. PMID: 8450246.
      View in: PubMed
    135. Correa AG, Edwards MS, Baker CJ. Vertebral osteomyelitis in children. Pediatr Infect Dis J. 1993 Mar; 12(3):228-33. PMID: 8451100.
      View in: PubMed
    136. Edwards MS, Rench MA, Hall MA, Baker CJ. Fibronectin levels in premature infants with late-onset sepsis. J Perinatol. 1993 Jan-Feb; 13(1):8-13. PMID: 8445454.
      View in: PubMed
    137. Hall MA, Edwards MS, Baker CJ. Complement and antibody participation in opsonophagocytosis of type IV and V group B streptococci. Infect Immun. 1992 Dec; 60(12):5030-5. PMID: 1452334; PMCID: PMC258273.
    138. Campbell JR, Baker CJ, Edwards MS. Influence of serotype of group B streptococci on C3 degradation. Infect Immun. 1992 Nov; 60(11):4558-62. PMID: 1398967; PMCID: PMC258202.
    139. Campbell JR, Diacovo T, Baker CJ. Serratia marcescens meningitis in neonates. Pediatr Infect Dis J. 1992 Oct; 11(10):881-6. PMID: 1408491.
      View in: PubMed
    140. Harvey BS, Baker CJ, Edwards MS. Contributions of complement and immunoglobulin to neutrophil-mediated killing of enterococci. Infect Immun. 1992 Sep; 60(9):3635-40. PMID: 1500172; PMCID: PMC257371.
    141. Baker CJ, Melish ME, Hall RT, Casto DT, Vasan U, Givner LB. Intravenous immune globulin for the prevention of nosocomial infection in low-birth-weight neonates. The Multicenter Group for the Study of Immune Globulin in Neonates. N Engl J Med. 1992 Jul 23; 327(4):213-9. PMID: 1614462.
      View in: PubMed
    142. Piedra PA, Kasel JA, Norton HJ, Garcia-Prats JA, Rayford Y, Estes MK, Hull R, Baker CJ. Description of an adenovirus type 8 outbreak in hospitalized neonates born prematurely. Pediatr Infect Dis J. 1992 Jun; 11(6):460-5. PMID: 1608683.
      View in: PubMed
    143. Schutze GE, Hall MA, Baker CJ, Edwards MS. Role of neutrophil receptors in opsonophagocytosis of coagulase-negative staphylococci. Infect Immun. 1991 Aug; 59(8):2573-8. PMID: 1855977; PMCID: PMC258058.
    144. Landers S, Moise AA, Fraley JK, Smith EO, Baker CJ. Factors associated with umbilical catheter-related sepsis in neonates. Am J Dis Child. 1991 Jun; 145(6):675-80. PMID: 1903588.
      View in: PubMed
    145. Campbell JR, Baker CJ, Edwards MS. Deposition and degradation of C3 on type III group B streptococci. Infect Immun. 1991 Jun; 59(6):1978-83. PMID: 2037359; PMCID: PMC257953.
    146. Baker CJ, Edwards MS. Methods for evaluating the protective activity of intravenous immunoglobulins for neonatal pathogens: entanglement or encouragement? Pediatrics. 1990 Dec; 86(6):995-7. PMID: 2123537.
      View in: PubMed
    147. Baker CJ. New uses of intravenous immune globulin in newborn infants. J Clin Immunol. 1990 Nov; 10(6 Suppl):47S-52S; discussion 52S-55S. PMID: 2081789.
      View in: PubMed
    148. Smith CL, Baker CJ, Anderson DC, Edwards MS. Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils. J Infect Dis. 1990 Aug; 162(2):489-95. PMID: 2197341.
      View in: PubMed
    149. Piedra PA, Kasel JA, Norton HJ, Gruber WC, Garcia-Prats JA, Baker CJ. Evaluation of an intravenous immunoglobulin preparation for the prevention of viral infection among hospitalized low birth weight infants. Pediatr Infect Dis J. 1990 Jul; 9(7):470-5. PMID: 2164655.
      View in: PubMed
    150. Sokol DM, Demmler GJ, Baker CJ. Unusual presentation of group B streptococcal ventriculitis. Pediatr Infect Dis J. 1990 Jul; 9(7):525-7. PMID: 2371087.
      View in: PubMed
    151. Baker CJ, Rench MA, Kasper DL. Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection. N Engl J Med. 1990 Jun 28; 322(26):1857-60. PMID: 2190087.
      View in: PubMed
    152. Baker CJ, Rench MA, Noya FJ, Garcia-Prats JA. Role of intravenous immunoglobulin in prevention of late-onset infection in low-birth-weight neonates. The Neonatal IVIG Study Group. Rev Infect Dis. 1990 May-Jun; 12 Suppl 4:S463-8; discussion S468-9. PMID: 2114036.
      View in: PubMed
    153. Baker CJ. Immunization to prevent group B streptococcal disease: victories and vexations. J Infect Dis. 1990 May; 161(5):917-21. PMID: 2182731.
      View in: PubMed
    154. Baker CJ, Noya FJ. Potential use of intravenous immune globulin for group B streptococcal infection. Rev Infect Dis. 1990 May-Jun; 12 Suppl 4:S476-82. PMID: 2194272.
      View in: PubMed
    155. Baker CJ. Antibiotic therapy in neonates whose mothers have received intrapartum group B streptococcal chemoprophylaxis. Pediatr Infect Dis J. 1990 Feb; 9(2):149-50. PMID: 2179842.
      View in: PubMed
    156. Dobson SR, Baker CJ. Enterococcal sepsis in neonates: features by age at onset and occurrence of focal infection. Pediatrics. 1990 Feb; 85(2):165-71. PMID: 2104974.
      View in: PubMed
    157. Butler KM, Rench MA, Baker CJ. Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J. 1990 Jan; 9(1):51-6. PMID: 2300413.
      View in: PubMed
    158. Edwards MS, Hall MA, Rench MA, Baker CJ. Patterns of immune response among survivors of group B streptococcal meningitis. J Infect Dis. 1990 Jan; 161(1):65-70. PMID: 2404076.
      View in: PubMed
    159. Patrick CC, Kaplan SL, Baker CJ, Parisi JT, Mason EO. Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates. Pediatrics. 1989 Dec; 84(6):977-85. PMID: 2587153.
      View in: PubMed
    160. Noya FJ, Rench MA, Courtney JT, Feldman S, Baker CJ. Pharmacokinetics of intravenous immunoglobulin in very low birth weight neonates. Pediatr Infect Dis J. 1989 Nov; 8(11):759-63. PMID: 2480576.
      View in: PubMed
    161. Patrick CC, Langston C, Baker CJ. Bacillus species infections in neonates. Rev Infect Dis. 1989 Jul-Aug; 11(4):612-5. PMID: 2505353.
      View in: PubMed
    162. Edwards MS, Baker CJ, Butler KM, Mason EO, Laurent JP, Cheek WR. Penetration of cefuroxime into ventricular fluid in cerebrospinal fluid shunt infections. Antimicrob Agents Chemother. 1989 Jul; 33(7):1108-10. PMID: 2782860; PMCID: PMC176071.
    163. Rench MA, Baker CJ. Group B streptococcal breast abscess in a mother and mastitis in her infant. Obstet Gynecol. 1989 May; 73(5 Pt 2):875-7. PMID: 2649829.
      View in: PubMed
    164. Baker CJ, Rench MA, Edwards MS, Carpenter RJ, Hays BM, Kasper DL. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. N Engl J Med. 1988 Nov 3; 319(18):1180-5. PMID: 3050524.
      View in: PubMed
    165. Patterson LE, Baker CJ, Rench MA, Edwards MS. Fibronectin and age-limited susceptibility to type III, group B Streptococcus. J Infect Dis. 1988 Aug; 158(2):471-4. PMID: 3042880.
      View in: PubMed
    166. Murphy FM, Baker CJ. Solitary hepatic abscess: a delayed complication of neonatal bacteremia. Pediatr Infect Dis J. 1988 Jun; 7(6):414-6. PMID: 3393401.
      View in: PubMed
    167. Kline MW, Kaplan SL, Baker CJ. Acute focal bacterial nephritis: diverse clinical presentations in pediatric patients. Pediatr Infect Dis J. 1988 May; 7(5):346-9. PMID: 3288948.
      View in: PubMed
    168. Butler KM, Baker CJ. Group F Streptococcus. An unusual cause of arthritis. Clin Orthop Relat Res. 1988 Mar; (228):261-4. PMID: 3342578.
      View in: PubMed
    169. Noya FJ, Rench MA, Garcia-Prats JA, Jones TM, Baker CJ. Disposition of an immunoglobulin intravenous preparation in very low birth weight neonates. J Pediatr. 1988 Feb; 112(2):278-83. PMID: 3339509.
      View in: PubMed
    170. Matson DO, Rouah E, Lee RT, Armstrong D, Parke JT, Baker CJ. Acanthameba meningoencephalitis masquerading as neurocysticercosis. Pediatr Infect Dis J. 1988 Feb; 7(2):121-4. PMID: 3344170.
      View in: PubMed
    171. Baker CJ, Edwards MS. Group B streptococcal infections. Perinatal impact and prevention methods. Ann N Y Acad Sci. 1988; 549:193-202. PMID: 3067638.
      View in: PubMed
    172. Campbell JR, Baker CJ, Metzger TG, Edwards MS. Functional activity of class-specific antibodies to type III, group B streptococcus. Pediatr Res. 1988 Jan; 23(1):31-4. PMID: 3277150.
      View in: PubMed
    173. Starke JR, Edwards MS, Langston C, Baker CJ. A mouse model of chronic pulmonary infection with Pseudomonas aeruginosa and Pseudomonas cepacia. Pediatr Res. 1987 Dec; 22(6):698-702. PMID: 3431954.
      View in: PubMed
    174. Butler KM, Baker CJ, Edwards MS. Interaction of soluble fibronectin with group B streptococci. Infect Immun. 1987 Oct; 55(10):2404-8. PMID: 3115897; PMCID: PMC260721.
    175. Baker CJ, Barrett FF, Clark DJ. Incidence of kanamycin resistance among Escherichia coli isolates from neonates. J Pediatr. 1974 Jan; 84(1):126-30. PMID: 12119935.
      View in: PubMed
    BAKER's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _